Status:

COMPLETED

Protective Efficacy of Flublok® Quadrivalent Versus Licensed Inactivated Influenza Vaccine in Adults ≥50 Years of Age

Lead Sponsor:

Protein Sciences Corporation

Conditions:

Influenza

Eligibility:

All Genders

50+ years

Phase:

PHASE3

Brief Summary

The goal of this study is to establish that Flublok Quadrivalent is non-inferior to fully licensed (traditional approval status) quadrivalent inactivated influenza vaccine (IIV4) in protecting against...

Detailed Description

The goal of this study is to establish that Flublok Quadrivalent is non-inferior to fully licensed (traditional approval status) quadrivalent inactivated influenza vaccine (IIV4) in protecting against...

Eligibility Criteria

Inclusion

  • Ambulatory adults aged 50 and older.
  • Medically stable, as determined by medical history and targeted physical examination. "Medically stable" is defined as no change in diagnoses or chronic medications (dose or class) for medical reasons in the 3 months prior to study.
  • Absence of underlying conditions that make participation in the study contrary to the subject's best interest.
  • Able to understand and comply with planned study procedures.
  • Provides written informed consent prior to initiation of any study procedure.

Exclusion

  • Known contraindication to either study vaccine (see product package inserts)
  • Receipt of any other influenza vaccine within 180 days prior to enrollment in this study.
  • Underlying disease or ongoing therapy that might cause immunocompromise, e.g. cytotoxic agents or supraphysiologic doses of corticosteroids, such that response to vaccination might be sub-optimal.

Key Trial Info

Start Date :

October 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2015

Estimated Enrollment :

9003 Patients enrolled

Trial Details

Trial ID

NCT02285998

Start Date

October 1 2014

End Date

May 1 2015

Last Update

October 27 2017

Active Locations (38)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 10 (38 locations)

1

Coastal Clinical Research

Mobile, Alabama, United States, 36608

2

Clinical Research Consortium Arizona

Tempe, Arizona, United States, 85283

3

Baptist Health Center for Clinical Research

Little Rock, Arkansas, United States, 72205

4

Northern California Clinical Research Center

Redding, California, United States, 96001